Search Results for "Drug"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug. Results 1911 to 1920 of 2624 total matches.

Continuous Glucose Monitoring

   
The Medical Letter on Drugs and Therapeutics • Feb 12, 2007  (Issue 1254)
Letter ® On Drugs and Therapeutics Continuous Glucose Monitoring Volume 49 (Issue 1254) February ...
A variety of glucose monitoring devices have been used in an effort to reduce the hypoglycemia and wide glucose excursions that complicate insulin treatment of diabetes. Since the last Medical Letter issue reviewing such devices, more continuous glucose monitoring (CGM) systems have become available. Five devices available now, and two expected to be marketed soon, are listed in the table on page 14. The FDA has approved continuous glucose devices only for the observation of glucose trends.
Med Lett Drugs Ther. 2007 Feb 12;49(1254):13-5 |  Show IntroductionHide Introduction

Ceftobiprole Medocaril (Zevtera) — A New Cephalosporin Antibiotic

   
The Medical Letter on Drugs and Therapeutics • Sep 15, 2025  (Issue 1737)
cephalosporin antibacterial drug, has been approved by the FDA for treatment of Staphylococcus aureus ...
Ceftobiprole medocaril sodium (Zevtera – Innoviva Specialty Therapeutics), a new IV cephalosporin antibacterial drug, has been approved by the FDA for treatment of Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis, acute bacterial skin and skin structure infections (ABSSSIs), and community-acquired bacterial pneumonia (CABP) (see Table 1). It is the second cephalosporin with activity against methicillin-resistant S. aureus (MRSA) to be approved in the US; ceftaroline (Teflaro), which was approved for treatment of ABSSSIs and CABP in 2010, was the...
Med Lett Drugs Ther. 2025 Sep 15;67(1737):149-52   doi:10.58347/tml.2025.1737d |  Show IntroductionHide Introduction

Alpha1-Proteinase Inhibitor for Alpha1-Antitrypsin Deficiency

   
The Medical Letter on Drugs and Therapeutics • Mar 11, 1988  (Issue 761)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Human alpha1-proteinase inhibitor (Prolastin Cutter), possibly better known as alpha1-antitypsin (ATT), is now available in the USA for replacement therapy in patients with emphysema who have a congential deficiency of the protein.
Med Lett Drugs Ther. 1988 Mar 11;30(761):29-30 |  Show IntroductionHide Introduction

Is Indapamide (Lozol) Safer Than A Thiazide?

   
The Medical Letter on Drugs and Therapeutics • Nov 17, 1989  (Issue 805)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Recent advertisements for indapamide (Lozol - Rorer), an oral antihypertensive/diuretic (Medical Letter, 26:17, 1984), claim that the drug, unlike thiazide diuretics, does not significantly increase serum cholesterol and has a minimal impact on potassium. Indapamide has no thiazide ring but, like chlorthalidone (Hygroton; and others) and hydrochlorothiazide (HydroDiuril; and others), it does have a sulfamoyl benzamide moiety, which is probably responsible for its natriuretic and diuretic effects. Unlike the thiazides, it also has a methylindoline moiety, which apparently decreases...
Med Lett Drugs Ther. 1989 Nov 17;31(805):103 |  Show IntroductionHide Introduction

Surfactant for Premature Infants With Respiratory Distress

   
The Medical Letter on Drugs and Therapeutics • Jan 12, 1990  (Issue 809)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
The US Food and Drug Administration recently approved ''Treatment IND';'; (investigational new drug) protocols for Exosurf (Burroughs Wellcome) and Survanta (Ross), two preparations of surfactant used for prevention and treatment of the respiratory distress syndrome (RDS) in premature newborn infants. Consequently, these drugs will be available to virtually every level-ΙΙΙ neonatal intensive-care unit in the USA.
Med Lett Drugs Ther. 1990 Jan 12;32(809):2-3 |  Show IntroductionHide Introduction

Pegademase

   
The Medical Letter on Drugs and Therapeutics • Sep 21, 1990  (Issue 827)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Pegademase (Adagen - Enzon), bovine adenosine deaminase (ADA) conjugated with polyethylene glycol (PEG), was recently approved by the US Food and Drug Administration as an 'orphan drug' for treatment of severe combined immunodeficiency disease (SCID). SCID due to inherited deficiency of ADA occurs in less than one per million births; until recently, without extraordinary isolation measures, it was usually fatal before the age of two.
Med Lett Drugs Ther. 1990 Sep 21;32(827):87-8 |  Show IntroductionHide Introduction

Ketoconazole Shampoo For Dandruff

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 1994  (Issue 927)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Ketoconazole (Nizoral - Janssen), an imidazole antifungal drug widely used in a tablet formulation for treatment of systemic fungal infections (Medical Letter 36:16, 1994) and as a topical preparation for fungal skin infections, is also available as a shampoo for treatment of seborrheic dandruff. The shampoo is sold only by prescription.
Med Lett Drugs Ther. 1994 Jul 22;36(927):68 |  Show IntroductionHide Introduction

Oral Pilocarpine for Xerostomia

   
The Medical Letter on Drugs and Therapeutics • Aug 19, 1994  (Issue 929)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Pilocarpine hydrochloride (Salagen- MGI Pharma), a cholinergic agonist long available in an ophthalmic formulation for treatment of glaucoma (Pilocar, and others), was recently approved by the US Food and Drug Administration (FDA) for oral treatment of radiation-induced xerostomia (dry mouth) in patients with head and neck cancer.
Med Lett Drugs Ther. 1994 Aug 19;36(929):76 |  Show IntroductionHide Introduction

Saw Palmetto for Benign Prostatic Hyperplasia

   
The Medical Letter on Drugs and Therapeutics • Feb 12, 1999  (Issue 1046)
The Medical Letter  On Drugs and Therapeutics www.medletter.com Published by The Medical ...
Saw palmetto, an "herbal supplement,"is now being heavily promoted to the general public for treatment of urinary symptoms related to prostatic enlargement. It has not been approved for any use by the FDA.
Med Lett Drugs Ther. 1999 Feb 12;41(1046):18 |  Show IntroductionHide Introduction

In Brief: Airborne

   
The Medical Letter on Drugs and Therapeutics • Jan 03, 2005  (Issue 1199)
The Medical Letter ® On Drugs and Therapeutics 1 FORWARDING OR COPYING IS A VIOLATION OF U.S ...
Patients may be asking about Airborne, a dietary supplement that is being heavily promoted for prevention and treatment of colds. It contains 7 herbal extracts, 3 vitamins, 2 amino acids, selenium, zinc and many other ingredients. Airborne Jr is available for children. There are some concerns. First, there is no conclusive evidence that this product or any of its ingredients prevents colds or shortens their duration. Second, the adult tablet contains 1 g of vitamin C, and the directions for use advise taking 1 tablet at the first sign of a cold and repeating the dose every 3 hours as...
Med Lett Drugs Ther. 2005 Jan 3;47(1199):4 |  Show IntroductionHide Introduction